Hayward, CA - IMPAX Laboratories, Inc. Food and Drug Administration (FDA) has granted final approval of the Company’s Abbreviated New Drug Application (ANDA) for generic versions of Xanax XR, (Alprazolam) 0. Pharmacia and Upjohn markets Xanax XR for the management of anxiety disorder or the short-term relief of symptoms of anxiety. IMPAX’ Global Pharmaceuticals division plans to launch the product soon. Drug Discovery Online | VertMarkets, Inc. read more
Technorati Tags: drug, anxiety, impax, xanax, xr, , anxiety disorder news
This entry was posted
on Sunday, June 3rd, 2007 at 4:47 am and is filed under Anxiety Disorder News.
You can follow any responses to this entry through the RSS 2.0 feed.
Responses are currently closed, but you can trackback from your own site.
Loading ...
